Cleared Traditional

K790474 - SZAMYL 6.5

K790474 is the FDA 510(k) clearance for SZAMYL 6.5 by Worthington Diagnostic Systems. It is a Class 2 Toxicology device (product code CIJ) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K790474 · Worthington Diagnostic Systems · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1979
Decision
57d
Days
Class 2
Risk

K790474 is an FDA 510(k) clearance for the SZAMYL 6.5. Classified as Saccharogenic, Amylase (product code CIJ), Class II - Special Controls.

Submitted by Worthington Diagnostic Systems (Mchenry, US). The FDA issued a Cleared decision on May 1, 1979 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1070 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Worthington Diagnostic Systems devices

Submission Details

510(k) Number K790474 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 1979
Decision Date May 01, 1979
Days to Decision 57 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 87d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIJ Saccharogenic, Amylase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1070
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - CIJ Saccharogenic, Amylase

All 29
Devices cleared under the same product code (CIJ) and FDA review panel - the closest regulatory comparables to K790474.
DADE COLORIMETRIC AMYLASE
K813529 · American Dade · Dec 1981
ULTRA ZYME PLUS AMYL #64982 & 65031
K812594 · Harleco · Oct 1981
CHEM-STRATE AMYLASE
K792479 · General Diagnostics · Dec 1979
ULTRA ZYME PLUS AMYL 64982, GILFORD 3500
K780513 · Harleco · May 1978
ULTRAZYME PLUS AMYL, CENTRIFICHEM APPLI.
K780141 · Harleco · Mar 1978
ENZYMATIC AMYLASE REAGENT KIT
K760415 · Beckman Instruments, Inc. · Nov 1976